CLINICAL PROBLEM-SOLVING: A Perfect Storm
3rd Nov 2005, 20:01 GMT
A 21-year-old male college student presented to the student health center with two days of extreme fatigue. Over the course of the previous two months, frequent headaches, difficulty concentrating, and decreased exercise tolerance had developed. He recently had had several days of nasal congestion and sore throat, but these symptoms had improved. A cursory physical examination was normal, but pulse oximetry revealed an oxygen saturation of only 55 percent.
CLINICAL PROBLEM-SOLVING: A Perfect Storm related news:
- The Perfect Storm — PinkFootball - It's not for boys
- 'Perfect Storm' Causes Dearth Of Candidates in Oil and Gas — CareerJournal.com
- CME: A Perfect Storm — New England Journal of Medicine -- Recent Issues
- The perfect economic storm — The Seattle Times
- NYC Mayor Steps Up Criticism of Opponent — www.heraldsun.com
- FORMULA 1 - RENAULT: Retro: the first 100% Renault win — noticias.info
- Office stereotyping, and how it stifles — azcentral.com | business
- Letters: Save engineering — The Daily Illini
- Poll: Bush Approval Sagging to New Lows — ABC News: WNT
- 'Category 7': A perfect storm of cheesiness — USATODAY.com Television - Top Stories
Latest news from New England Journal of Medicine -- Recent Issues:
- EARLY RELEASE: Reducing the Door-to-Balloon Time for Myocardial Infarction with ST-Segment Elevation
- EARLY RELEASE: Strategies for Reducing the Door-to-Balloon Time in Acute Myocardial Infarction
- EARLY RELEASE: Myocardial Infarction and the Open-Artery Hypothesis
- EARLY RELEASE: Coronary Intervention for Persistent Occlusion after Myocardial Infarction
- PERSPECTIVE: Recalibrating Medicare Payments for Inpatient Care
- PERSPECTIVE: Violence and Mental Illness -- How Strong is the Link?
- PERSPECTIVE: Murder or Mercy? Hurricane Katrina and the Need for Disaster Training
- ORIGINAL ARTICLE: Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
- ORIGINAL ARTICLE: Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
- ORIGINAL ARTICLE: Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia